About Aperiam Bio
Aperiam Bio is a company based in United States founded in 2019.. Aperiam Bio has raised $13 million across 2 funding rounds from investors including OMX Ventures, Civilization Ventures and Axial. Aperiam Bio offers products and services including Technical Reagents, Cosmetics Enzymes, and Pulmonary Biologics. Aperiam Bio operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and PolyPeptide, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13 M (USD)
in 2 rounds
-
Latest Funding Round
$9 M (USD), Seed
Nov 29, 2023
-
Investors
OMX Ventures
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aperiam Bio
Aperiam Bio offers a comprehensive portfolio of products and services, including Technical Reagents, Cosmetics Enzymes, and Pulmonary Biologics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables viable manufacturing of inaccessible proteins for partners.
Provides shelf-stable enzymes for new cosmetic actives applications.
Develops proteins that retain activity for medical nebulization uses.
Unlock access to complete
Unlock access to complete
Funding Insights of Aperiam Bio
Aperiam Bio has successfully raised a total of $13M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $9 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $9.0M
-
First Round
First Round
(27 Sep 2023)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Seed - Aperiam Bio | Valuation | OMX Ventures | |
| Sep, 2023 | Amount | Seed - Aperiam Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aperiam Bio
Aperiam Bio has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include OMX Ventures, Civilization Ventures and Axial. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in transformative biotech companies by OMX Ventures.
|
Founded Year | Domain | Location | |
|
Venture capital is provided to health tech and biology innovations.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aperiam Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aperiam Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aperiam Bio Comparisons
Competitors of Aperiam Bio
Aperiam Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and PolyPeptide, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Company specializing in development of Biosimilars
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO and analytical services for peptide development are provided.
|
|
| domain | founded_year | HQ Location |
Ocelot Bio is a CDMO specializing in peptide manufacturing services.
|
|
| domain | founded_year | HQ Location |
Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aperiam Bio
Frequently Asked Questions about Aperiam Bio
When was Aperiam Bio founded?
Aperiam Bio was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Where is Aperiam Bio located?
Aperiam Bio is headquartered in United States.
Is Aperiam Bio a funded company?
Aperiam Bio is a funded company, having raised a total of $13M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4M, raised on Sep 27, 2023.
What does Aperiam Bio do?
Aperiam Bio was founded in 2019 in the United States. Proteins for industrial and therapeutic uses are produced through biotechnology processes. Operations center on the development and manufacturing of these proteins for sector-specific needs. The company operates within the biotech industry, with a focus on protein-based solutions. Its online presence is maintained via aperiambio.com, supporting information on activities and contacts.
Who are the top competitors of Aperiam Bio?
Aperiam Bio's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.
What products or services does Aperiam Bio offer?
Aperiam Bio offers Technical Reagents, Cosmetics Enzymes, and Pulmonary Biologics.
Who are Aperiam Bio's investors?
Aperiam Bio has 4 investors. Key investors include OMX Ventures, Civilization Ventures, Axial, and KdT Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.